Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression.
Incorporated in June 2007
Origin: Oxford University, Department of Pathology
Biomimetic spinning of fibres.
Incorporated in March 2002
Origin: Oxford University
Gene-based Therapeutics.
Incorporated in August 1996
Origin: Oxford University, Department of Biochemistry
Water quality monitoring devices based on electrochemical (bio)sensors.
Incorporated in August 2000
Origin: Oxford University, Department of Chemistry
Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.
Incorporated in September 2013
Origin: Oxford University, Department of Chemistry
Software and patented approach to differential diagnosis of cognitive diseases
Incorporated in April 2019
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
Pioneering biomarker technologies for cancer therapies.
Incorporated in December 2011
Origin: Oxford University, Radcliffe Department of Oncology
Oxford Consultants for Social Inclusion (OCSI) helps local government identify deprived neighbourhoods, target resources, evaluate programme effectiveness and strengthen regeneration bids.
Incorporated in August 2003
Origin: Oxford University, Department of Social Policy and Intervention
Screensavers for drug candidates.
Incorporated in December 2001
Origin: Oxford University, Department of Chemistry
New tuberculosis vaccine – MVA85A.
Incorporated in July 2008
Developing tiny metallic mesh tube devices to treat patients suffering from brain aneurysms.
Incorporated in December 2015
Origin: Oxford University, Department of Engineering Science
Incorporated in March 2009
Origin: Oxford University, Department of Computer Science
Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.
Incorporated in September 2015
Origin: Oxford University, Department of Engineering Science
DNA technology
Incorporated in July 1997
Origin: Oxford University, Department of Biochemistry
Proteomics.
Incorporated in September 1988
Origin: Oxford University, Department of Chemistry
Carbon-free transformation of ammonia waste.
Incorporated in March 2021
Origin: Oxford University, Department of Chemistry
Sensor technology based on optical microcavities used in scientific instruments and chemical sensors.
Incorporated in June 2018
Origin: Oxford University, Department of Materials
Contact: Adam Workman
Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.
Incorporated in October 2011
Origin: Oxford University, Department of Materials
Oxford Immunotec is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. In 2021, Oxford Immunotec was acquired by PerkinElmer.
Incorporated in October 2002
Origin: Oxford University, Nuffield Department of Clinical Medicine
Technology products and services.
Incorporated in April 1958
Origin: Oxford University, Department of Physics
